Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with Covid-19
A propensity matched cohort study
Bibliographic Data
| ID | 23544895 |
|---|---|
| Authors | Kamal Matli, Nibal Chamoun (0000-0002-0987-296X), Aya Fares, Victor Zibara (0000-0002-3017-4621), Soad Al-Osta, Rabih Nasrallah, Pascale Salameh (0000-0002-4780-0772), Jacques Mokhbat, Georges Ghanem (0009-0006-5608-7653) |
| Year | 2021 |
| Volume | 8 |
| Issue | 2 |
| Pages | e001785 |
| Publication date | 2021-10-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Open Heart (JOURNAL) |
| Journal identifiers | ISSN: 2053-3624 • E-ISSN: 2053-3624 |
| Publisher | BMJ (PUBLISHER • GB) |
| DOI | 10.1136/openhrt-2021-001785 |
| OpenAlex | W34611018 |
| Language | EN |
| Citations received | 7 |
| References cited | 34 |
The use of combined anticoagulant and antiplatelet agents or TAC alone in hospitalised patients with COVID-19 was associated with a better outcome in comparison to PAC alone without an increase in the risk of major and minor bleeds. Sufficiently powered randomised controlled trials are needed to further evaluate the safety and efficacy of combining antiplatelet and anticoagulants agents or using TAC in the management of patients with COVID-19 infection.
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (Covid-19) Outbreak in China
| Citations per year | 0.18 |
|---|---|
| Citation span | 1987 - 2022 (36) |
| Highly cited | No |